Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1996
03/14/1996CA2198018A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996CA2197888A1 Modified human c3 proteins
03/14/1996CA2197873A1 A novel haemopoietin receptor
03/14/1996CA2197714A1 Therapeutic treatment of clostridium difficile associated diseases
03/13/1996EP0700999A2 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
03/13/1996EP0700998A1 Recombinant mersacidin and a method for production
03/13/1996EP0700997A1 Production in bacteria and yeast of hemoglobin and analogues thereof
03/13/1996EP0700930A1 Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide
03/13/1996EP0700929A2 Peptide derived from cedar pollen allergens and uses thereof
03/13/1996EP0700928A1 Nucleic acid-binding oligomers for therapy and diagnostics
03/13/1996EP0700684A2 Composition containing prothrombincomplex-concentrate and at least one additional component which activates the coagulation, as antidote for blood-anticoagulants
03/13/1996EP0700683A1 Insulin analog formulations
03/13/1996EP0700682A2 Medicament containing prothrombin for antagonizing blood-anticoagulents
03/13/1996EP0700681A1 Nutritional transfusion for peripheral vein administration
03/13/1996EP0700444A1 Immunotoxins comprising gelonin and an antibody
03/13/1996EP0700443A1 Cho cell sialidase disrupted by recombinant dna technology
03/13/1996EP0700440A1 Regulator of contact-mediated hemolysin
03/13/1996EP0700439A1 Lymphocyte chemoattractant factor and uses thereof
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700435A1 Transgenic mammals lacking expression of particular cd45 isoforms
03/13/1996EP0700430A1 Methods for selectively stimulating proliferation of t cells
03/13/1996EP0700402A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
03/13/1996EP0700401A1 Human calcium sensor
03/13/1996EP0700305A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
03/13/1996EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
03/13/1996EP0700303A1 Enteral nutritional product
03/13/1996EP0700302A1 Method of treating diabetes mellitus
03/13/1996EP0700301A1 Peptides and compounds that bind to elam-1
03/13/1996EP0700300A1 Purification of plasma proteins
03/13/1996EP0700299A1 Oxygen-reduced aqueous solution of factor viii
03/13/1996EP0700298A1 Therapeutic use of hemoglobin in the treatment of blood vessel blockage
03/13/1996EP0700295A1 Vitamin b 12? mediated oral delivery systems for gcsf and epo
03/13/1996EP0700287A1 Arylating medicaments
03/13/1996EP0690841A4 Synthetic matrix metalloprotease inhibitors and uses thereof
03/13/1996EP0665746A4 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF-g(a)PE 40?ab.
03/13/1996EP0566661B1 Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals
03/13/1996EP0562036B1 Container system for storage stable pharmaceuticals
03/13/1996EP0561927B1 Pharmaceutical compositions for the treatment of b-cell malignancies
03/13/1996EP0550691B1 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides
03/13/1996EP0502962B1 Hirudinmuteins and their polyalkylene glycol conjugates
03/13/1996EP0502926B1 Anti-thrombotic peptides and pseudopeptides
03/13/1996EP0497929B1 Composition for stabilizing blood plasma during pasteurization
03/13/1996EP0491007B1 Structural alterations of the egf receptor gene in human gliomas
03/13/1996EP0472657B1 Method and composition for the treatment of thrombosis in a mammal
03/13/1996EP0472588B1 Use of alpha-d-galactosidase for the preparation of a pharmaceutical composition for reducing gastro-intestinal distress due to alpha-d-galactoside-linked sugars.
03/13/1996EP0469036B1 Composition and treatment with biologically active peptides and antibiotic
03/13/1996EP0438497B1 Vasopermeability-enhancing conjugates
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996EP0428602B1 Polypeptides and dna encoding same
03/13/1996EP0401384B1 Chemically modified granulocyte colony stimulating factor
03/13/1996CN1118601A Inhibitors of herpes viral ribonucleotide reductase
03/13/1996CN1118573A Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
03/13/1996CN1031267C Compounds for anti-dementia medicine and its usage
03/13/1996CN1031242C 化妆品组合物 Cosmetic composition
03/13/1996CA2157851A1 Insulin analog formulations
03/13/1996CA2144580A1 Pharmaceutical composition for use as a retinal pigment epithelial cell growth agent
03/13/1996CA2131868A1 Suppression of nephritis-induced protein excretion by anti-il-8
03/12/1996US5498779 Anticoagulants and treatment of asthma
03/12/1996US5498728 Osteoporosis
03/12/1996US5498698 Megakaryocyte potentiator
03/12/1996US5498697 Protein possessing metastasis-inhibitory activity
03/12/1996US5498601 Rgd sequence
03/12/1996US5498600 Platelet derived growth factor, wound healing
03/12/1996US5498599 Methods for stimulating platelet production
03/12/1996US5498598 Composition for nasal administration of desmopressin
03/12/1996US5498536 Chondroitinase II from Proteus vulgaris
03/12/1996US5498499 Peptides and antibodies that inhibit platelet adhesion
03/12/1996US5498427 Solutions for the perfusion, preservation and reperfusion of organs
03/12/1996US5498423 Method for correcting plasma melatonin levels and pharmaceutical formulation comprising melatonin
03/12/1996US5498410 Method for the treatment of eosinophil-associated conditions with anionic polymers
03/12/1996CA2053317C Active carbonates of polyalkylene oxides for modification of polypeptides
03/12/1996CA1338163C Process for the preparation of n-alkylated dipeptides and their esters
03/12/1996CA1338162C Process for the preparation of n-alkylated dipeptides and their esters
03/11/1996CA2157980A1 Allergenic peptides from cryptomeria japonica and their uses
03/07/1996WO1996007102A1 Therapeutic remodeling in aids
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006942A1 Genetically altered t-cells
03/07/1996WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006938A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006937A1 Improvements in production of proteins in host cells
03/07/1996WO1996006933A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
03/07/1996WO1996006863A1 Agents for inducing apoptosis and applications of said agents in therapy
03/07/1996WO1996006862A1 Gabaa receptor epsilon subunit
03/07/1996WO1996006861A1 Trefoil peptide dimer
03/07/1996WO1996006860A2 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
03/07/1996WO1996006859A1 Trophic factors for central nervous system regeneration
03/07/1996WO1996006857A1 Immunostimulatory agents
03/07/1996WO1996006855A1 NEW PEPTIDE DERIVATIVES WITH δ OPIOID RECEPTOR ANTAGONIST OR MIXED ν AGONIST/δ ANTAGONIST EFFECTS
03/07/1996WO1996006642A1 Allogeneic and xenogeneic transplantation
03/07/1996WO1996006641A1 Conjugates of vascular endothelial growth factor with targeted agents
03/07/1996WO1996006637A1 Method of inhibiting tissue ischemia and reperfusion injury
03/07/1996WO1996006636A1 Topical anti-inflammatory composition and method
03/07/1996WO1996006635A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996WO1996006634A1 Method for the treatment of indirect inguinal hernias and related conditions
03/07/1996WO1996006633A2 Methods of inducing hair growth and coloration
03/07/1996WO1996006632A1 Compositions and methods for delivery of polypeptides
03/07/1996WO1996006631A1 Vancomycin hydrochloride suspensions for peroral use and for filling into soft gelatin capsules
03/07/1996WO1996006630A1 Methods and compositions for modulating a t cell response
1 ... 2799 2800 2801 2802 2803 2804 2805 2806 2807 2808 2809 2810 2811 2812 2813 2814 2815 2816 2817 2818 2819 ... 3163